— Know what they know.
Not Investment Advice

OTO.MI MIL

Otofarma S.p.A.
1W: -4.9% 1M: -3.3% 3M: -15.9% YTD: -52.2% 1Y: -57.7%
€2.32 ($2.61)
+0.02 (+0.87%)
 
Weekly Expected Move ±3.8%
€2 €2 €2 €2 €2
MIL · Healthcare · Medical - Devices · Tech Score Sell · Power 40 · €13.8M mcap · 639302 float · 1.18% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap€13.8M ($15.5M)
52W Range2.26-5.72
Volume1,200
Avg Volume7,527
Beta-0.42
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOGiovanna Incarnato Bartolomucci
Employees115
SectorHealthcare
IndustryMedical - Devices
IPO Date2025-08-06
Viale Gramsci 17/B
Naples, NA 80122
IT
39 0081 18 54 30 72
About Otofarma S.p.A.

Otofarma S.p.A. specializes in the manufacturing and distribution of bespoke hearing solutions. The company's comprehensive product range includes custom-fit, in-the-canal (ITC), and behind-the-ear (BTE) hearing aids, along with rechargeable options and various essential accessories. Founded in 2016, the firm's main office is located in Napoli, Italy, complemented by another branch in Milan. Effective August 5, 2025, Otofarma S.p.A. will function as a subsidiary of Bartolomucci Holding s.r.l.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms